Cencora, Inc. COR
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Cencora, Inc. (COR) EV/Sales
As of 25 September 2026, Cencora, Inc. (COR) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (March 2026); the current reading is higher than 92% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | 27.19% |
| FY2024 | 0.2× | 6.54% |
| FY2023 | 0.1× | 14.70% |
| FY2022 | 0.1× | (4.77%) |
| FY2021 | 0.1× | 31.67% |
| FY2020 | 0.1× | (0.58%) |
| FY2019 | 0.1× | (23.03%) |
| FY2018 | 0.1× | 4.39% |
| FY2017 | 0.1× | (0.62%) |
| FY2016 | 0.1× | (21.55%) |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.2× | (11.98%) |
| Mar 2026 | 0.2× | (1.50%) |
| Dec 2025 | 0.2× | 10.81% |
| Sep 2025 | 0.2× | (1.83%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| COR Cencora, Inc. | 0.2× |
| CAH Cardinal Health, Inc. compare | 0.2× |
| MCK McKesson Corporation compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.4× |
| ACH Accendra Health, Inc. compare | 0.9× |
| HSIC Henry Schein, Inc. compare | 0.9× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| FOCL FocalTherics compare | 2.4× |
| Medical Distribution industry median | 0.6× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement